Literature DB >> 12686464

Production of recombinant human relaxin 3 in AtT20 cells.

Hideki Kizawa1, Kazunori Nishi, Yoshihiro Ishibashi, Masataka Harada, Tsuneo Asano, Yasuaki Ito, Nobuhiro Suzuki, Shuji Hinuma, Yukio Fujisawa, Haruo Onda, Osamu Nishimura, Masahiko Fujino.   

Abstract

Relaxin 3 has been reported recently as a member of the insulin/IGF/relaxin family. To clarify the function of relaxin 3, we prepared recombinant human relaxin 3 using a mouse adrenocorticotrophic hormone (ACTH)-secreting cell line, AtT20. To detect a mature form of recombinant human relaxin 3, a competitive enzyme immunoassay (EIA) was developed using a monoclonal antibody (mAb; HK4-144-10), which was raised for the N-terminal peptide of human relaxin 3 A-chain. We detected immunoreactive (ir-) relaxin 3 in the culture supernatant of AtT20 cells stably transfected with human relaxin 3 cDNA. After treatment with 5 microM forskolin for 3 days, the concentration of the ir-relaxin 3 in the culture supernatant reached 12 nM. Ir-relaxin 3 was purified from the culture supernatant by a combination of various chromatographies. By analyses of N-terminal amino acid sequence and electrospray ionization mass spectrometry (ESI-MS), we confirmed that the purified material was a mature form of human relaxin 3. The recombinant human relaxin 3 thereby obtained increased intracellular cAMP production in THP-1 cells. Our results demonstrate that the expression of relaxin 3 cDNA in AtT20 cells is a useful tool to produce a bioactive and mature form of relaxin 3.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686464     DOI: 10.1016/s0167-0115(02)00304-x

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  8 in total

1.  Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus.

Authors:  Yoshihisa Watanabe; Yasumasa Miyamoto; Tomoyuki Matsuda; Masaki Tanaka
Journal:  J Mol Neurosci       Date:  2010-11-12       Impact factor: 3.444

2.  Relaxin-3/RXFP3 signalling in mouse hypothalamus: no effect of RXFP3 activation on corticosterone, despite reduced presynaptic excitatory input onto paraventricular CRH neurons in vitro.

Authors:  C Zhang; D V Baimoukhametova; C M Smith; J S Bains; Andrew L Gundlach
Journal:  Psychopharmacology (Berl)       Date:  2017-03-17       Impact factor: 4.530

3.  Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice.

Authors:  Xiaodong Mu; Maria L Urso; Kiley Murray; Freddie Fu; Yong Li
Journal:  Am J Pathol       Date:  2010-10-07       Impact factor: 4.307

4.  Heterogeneous responses of nucleus incertus neurons to corticotrophin-releasing factor and coherent activity with hippocampal theta rhythm in the rat.

Authors:  Sherie Ma; Anna Blasiak; Francisco E Olucha-Bordonau; Anthony J M Verberne; Andrew L Gundlach
Journal:  J Physiol       Date:  2013-05-13       Impact factor: 5.182

5.  Relaxin-3-deficient mice showed slight alteration in anxiety-related behavior.

Authors:  Yoshihisa Watanabe; Atsushi Tsujimura; Keizo Takao; Kazunori Nishi; Yasuaki Ito; Yoshitaka Yasuhara; Yasuhito Nakatomi; Chihiro Yokoyama; Kenji Fukui; Tsuyoshi Miyakawa; Masaki Tanaka
Journal:  Front Behav Neurosci       Date:  2011-08-17       Impact factor: 3.558

6.  Gram scale preparation of clozapine N-oxide (CNO), a synthetic small molecule actuator for muscarinic acetylcholine DREADDs.

Authors:  Phillip L van der Peet; Christian Gunawan; Alaa Abdul-Ridha; Sherie Ma; Daniel J Scott; Andrew L Gundlach; Ross A D Bathgate; Jonathan M White; Spencer J Williams
Journal:  MethodsX       Date:  2018-03-23

7.  Targeted viral vector transduction of relaxin-3 neurons in the rat nucleus incertus using a novel cell-type specific promoter.

Authors:  Alexander D Wykes; Sherie Ma; Ross A D Bathgate; Andrew L Gundlach
Journal:  IBRO Rep       Date:  2019-12-13

8.  Mapping Cell Types and Efferent Pathways in the Ascending Relaxin-3 System of the Nucleus Incertus.

Authors:  Nailyam Nasirova; Lely A Quina; Glenn Morton; Andrew Walker; Eric E Turner
Journal:  eNeuro       Date:  2020-11-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.